Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jejuni NCTC11168
Gastric diseases are increasing with the infection of Campylobacter jejuni. Late stages of infection lead to peptic ulcer and gastric carcinoma. C. jejuni infects people within different stages of their life, especially childhood, causing severe diarrhea; it infects around two-thirds of the world po...
Saved in:
| Main Authors: | Mohammed Yosri, Basma H. Amin, Nermine N. Abed, Amal S. Elithy, Sayed M. Kareem, Nagwa M. Sidkey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2020/3591276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Throughput Method for Analysis of Repeat Number for 28 Phase Variable Loci of Campylobacter jejuni Strain NCTC11168.
by: Lea Lango-Scholey, et al.
Published: (2016-01-01) -
Campylobacter Jejuni and Thrombotic Thrombocytopenic Purpura
by: Roman Jaeschke, et al.
Published: (1990-01-01) -
Campylobacter jejuni causes colorectal cancer
by: Pascal Alain Gervaz, et al.
Published: (2022-01-01) -
Genome dynamics of Campylobacter jejuni in response to bacteriophage predation.
by: Andrew E Scott, et al.
Published: (2007-08-01) -
Genomic diversity of Campylobacter jejuni and Campylobacter coli isolated from the Ethiopian dairy supply chain.
by: Abera Admasie, et al.
Published: (2024-01-01)